Online Extras

These three steps should take place in order to ensure an optimal site selection.

There are many benefits for sites adopting electronic informed consent and it is vital that site study teams are not bystanders in the move towards its use.

The clinical trials industry craves blockchain technology to provide data safety and authenticity.

Biomarker and specialty lab data are increasingly being incorporated in FDA submissions given the robust insights they provide on key clinical objectives, including pharmacological effects, and drug safety and effectiveness.

Numerous factors can adversely impact study startup and its efficiency, in an industry plagued by rising development costs and increasing complexities.

Virtual care technology is emerging as a valuable tool for clinical trials, helping to improve recruiting and strengthen retention while optimizing resources for the overall study.

The GS1 Standards will enable more efficient processes at institutions that are already using an electronic inventory system to manage investigational products.

This article discusses real-time data capture and analytics in clinical trials.

A sex-bias that significantly impacts the advancement of women’s health exists in both preclinical and clinical research.

Today, a data-driven approach to feasibility assessment can help ensure that a sponsor’s clinical research plan is designed to enroll the right patients, rely on the right investigators, and take place in the right countries for success.

Metabolomics can make a positive impact from early drug discovery through clinical development and beyond.

Updated employee announcements, business news, awards, and recognition in the industry today.

The Ukrainian Government has implemented several important measures to make the country more attractive for clinical trials.

Updated employee announcements, business news, awards, and recognition in the industry today.

Steve Young looks at the tremendous benefits that organizations stand to reap by effectively implementing the core principles included in the ICH update and the significant opportunities that the application of intelligent analytics and centralized statistical monitoring may present.

An overview of quantifiable techniques when choosing the parameters in dynamic randomization for clinical trial enrollment.

Sponsors and CROs are looking into implementation of a Risk Based Monitoring approach to their clinical trials to achieve the objectives related to enhanced data quality, better monitoring of patient safety, and creating efficiencies in overall operations.

Turning community clinics into research sites requires provision of personnel, processes, technology, and infrastructure to conduct clinical research.

An RBM survey conducted in 2014 was repeated in 2016 in order to find out, how knowledge and practical experience with RBM have changed over that time period.

With several systems existing to measure performance, the most significant are the course of patient recruitment, how many patients complete the study, as well as the quality of the data generated.

ZS Associates specify the four pillars of patient centricity that can help the demands and complexities of clinical trials.

Updated employee announcements, business news, awards, and recognition in the industry today.

Cancer vaccine-based immunotherapy may help overcome the resistance of certain tumors to immune checkpoint inhibitors, while immune checkpoint inhibitors may enhance the efficacy of cancer vaccine therapies.

With recent reports indicating that organizations do not have a way of tracking and managing the timeliness of data entry or of site payments, The Metrics Champion Consortium wanted to see if there were opportunities to align incentives in the industry so that both sites and sponsors can achieve their goals with positive impact on clinical trials and patients.

Because of the growing rate of voice assistant applications, such as Alexa, healthcare and life sciences organizations are beginning to design a range of scenarios for deploying these voice assistant platforms in the clinical trial setting.

CRO's and sponsors are taking clinical trials to homes. These in-home trials can address participation issues and provide added convenience plus support for patients, but they also come with their own set of risks.

Updated employee announcements, business news, awards, and recognition in the industry today.

Managing clinical trial supply is not easy for the pharmaceutical industry between drug overages and right medical distribution. However, this is an important topic for sponsors to consider because the right strategy can help save money and reduce unnecessary spending.

This article discusses the adoption of RBQM in academic settings and the lessons that were learned.

A review of a recent FSP in which the CRO partner assumed clinical monitoring and site support responsibility for more than 50 ongoing trials.